HISTO is China's first and largest independent third-party pathological diagnostic center, founded in 2011. As the pioneer in its field, the company has positioned itself as the most extensive independent pathology diagnostic center ever established in China. Specializing in the Health Care industry, HISTO recently received a Series B investment on 28 May 2024 from Puhua Capital and Changxing Financial Holdings. This investment not only reflects the market's confidence in the company but also signifies potential growth and expansion opportunities for HISTO in the ever-evolving healthcare sector.
HISTO
As China's pioneering and most extensive independent pathology diagnostic center ever established
Founded 2011
Series B
Total: $23.00M
Health Care
General Information
Company Name
HISTO
Founded Year
2011
Industries
Health Care
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with HISTO. To contact HISTO, visit histo.cn.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About HISTO
Taxonomy: pathology, diagnostic center, China, independent, pioneering, medical services, laboratory services
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | Undisclosed | 2 |
|
28 May 2024 |
| Series B | Undisclosed | 2 |
|
28 Mar 2021 |
| Series A | CNY10.00M | 3 |
|
15 Jan 2019 |
| Series A | CNY10.00M | 1 |
Xinxin Liye
|
26 Sep 2017 |
| Angel Round | CNY3.00M | 1 |
Xuying Touzi
|
30 Oct 2015 |
HISTO Alternatives & Competitors
View All Alternatives
HISTO vs
SaraPath Diagnostics
United States
Sarasota's premier advanced diagnostic pathology and specialty laboratory
52 employees
Health Care
HISTO vs
Aarthi Scans & Labs
India
India's Largest Integrated (Radiology+Pathology) Diagnostic Chain
Private Equity
588 employees
Health Care
HISTO vs
Sonora Quest Laboratories a trusted leader in diagnostic and information services.
1299 employees
Health Care
FAQ About HISTO
As China's pioneering and most extensive independent pathology diagnostic center ever established
HISTO was founded in 2011.
HISTO operates in Health Care. Its work centres on pathology, diagnostic center, China and independent.
HISTO has completed 5 funding rounds, raising a total of $23.00M. The latest funding stage is Series B.
Top alternatives and competitors to HISTO include SaraPath Diagnostics, Aarthi Scans & Labs, Sonora Quest Laboratories/ Laboratory Sciences of Arizona, Biosphere Lab, CorePlus Servicios Clínicos y Patológicos, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HISTO and SaraPath Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for HISTO, https://bouncewatch.com/company/histo, updated 26 December 2024. When citing, please name BounceWatch and link this page.
